That means an HIV-negative person who may be at risk of contracting the disease can take certain ARVs to protect themselves, before they become exposed.
And I could start manufacturing ARV drugs and start from building the factory, supervising the construction of the factory, and teaching local people to manufacture ARV drugs.
Many at-risk HIV negative people across the world do not have access to PrEP or ARVs, and those who are HIV positive may experience challenges to taking ARVs.
Antiretroviral drugs or ARV's, in Ivory Coast are financed by initiatives like The Global Fund to Fight AIDS along with the government, but the demand remains high and so is the cost.
Doctors today have no trouble keeping HIV under control in people who are infected, thanks to antiretroviral (ARV) drugs, which stop the virus from replicating once it finds its way inside healthy cells.
Only 9 of the 152 countries surveyed are still reporting disruptions; and in June, 24 countries reported less than 3 months supply of ARVs, while now only 12 report a critically low stock.
In the period from 1996 to 2017, we almost halved the number of new HIV infections, and for the millions of people who still live with the virus, ARV treatments enable most to lead long and healthy lives.